• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 水平与非酒精性脂肪性肝病的关系:潜在的混杂变量。

Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables.

机构信息

Policlinico Umberto I Hospital, Sapienza University of Rome, Viale Regina Elena, 324 00161-Rome, Italy.

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Viale Regina Elena, 324 00161- Rome, Italy.

出版信息

Mini Rev Med Chem. 2019;19(4):310-332. doi: 10.2174/1389557518666181025153712.

DOI:10.2174/1389557518666181025153712
PMID:30360708
Abstract

Nonalcoholic fatty liver disease (NAFLD), historically considered to be the hepatic component of the metabolic syndrome, is a spectrum of fat-associated liver conditions, in the absence of secondary causes, that may progress to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. Disease progression is closely associated with body weight or fatness, dyslipidemia, insulin resistance, oxidative stress, and inflammation. Recently, vitamin D deficiency has been linked to the pathogenesis and severity of NAFLD because of vitamin D "pleiotropic" functions, with roles in immune modulation, cell differentiation and proliferation, and regulation of inflammation. Indeed, several studies have reported an association between vitamin D and NAFLD/NASH. However, other studies have failed to find an association. Therefore, we sought to critically review the current evidence on the association between vitamin D deficiency and NAFLD/NASH, and to analyze and discuss some key variables that may interfere with this evaluation, such as host-, environment-, and heritability-related factors regulating vitamin D synthesis and metabolism; definitions of deficient or optimal vitamin D status with respect to skeletal and nonskeletal outcomes including NAFLD/NASH; methods of measuring 25(OH)D; and methods of diagnosing NAFLD as well as quantifying adiposity, the cardinal link between vitamin D deficiency and NAFLD.

摘要

非酒精性脂肪性肝病(NAFLD),历史上被认为是代谢综合征的肝脏成分,是一系列与脂肪相关的肝脏疾病,在没有继发性原因的情况下,可能进展为非酒精性脂肪性肝炎(NASH)、纤维化和肝硬化。疾病进展与体重或肥胖、血脂异常、胰岛素抵抗、氧化应激和炎症密切相关。最近,由于维生素 D 的“多效性”功能,维生素 D 缺乏与 NAFLD 的发病机制和严重程度有关,其在免疫调节、细胞分化和增殖以及炎症调节中发挥作用。事实上,几项研究报告了维生素 D 与 NAFLD/NASH 之间的关联。然而,其他研究未能发现这种关联。因此,我们试图批判性地回顾目前关于维生素 D 缺乏与 NAFLD/NASH 之间关联的证据,并分析和讨论一些可能干扰这种评估的关键变量,例如调节维生素 D 合成和代谢的宿主、环境和遗传性因素;关于骨骼和非骨骼结局(包括 NAFLD/NASH)的维生素 D 缺乏或最佳状态的定义;25(OH)D 的测量方法;以及 NAFLD 的诊断方法以及肥胖程度的量化,肥胖是维生素 D 缺乏与 NAFLD 之间的主要联系。

相似文献

1
Association between Vitamin D Levels and Nonalcoholic Fatty Liver Disease: Potential Confounding Variables.维生素 D 水平与非酒精性脂肪性肝病的关系:潜在的混杂变量。
Mini Rev Med Chem. 2019;19(4):310-332. doi: 10.2174/1389557518666181025153712.
2
Micronutrient Antioxidants and Nonalcoholic Fatty Liver Disease.微量营养素抗氧化剂与非酒精性脂肪性肝病
Int J Mol Sci. 2016 Aug 23;17(9):1379. doi: 10.3390/ijms17091379.
3
Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis.维生素 D 与非酒精性脂肪性肝炎的胰岛素抵抗及疾病严重程度的关系。
J Hepatol. 2015 Feb;62(2):405-11. doi: 10.1016/j.jhep.2014.08.040. Epub 2014 Sep 6.
4
Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).非酒精性脂肪性肝病 (NAFLD) 中维生素 A 代谢紊乱。
Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029.
5
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的当前药物治疗方法。
World J Gastroenterol. 2015 Apr 7;21(13):3777-85. doi: 10.3748/wjg.v21.i13.3777.
6
Vitamin D Status and Bone Mineral Density in Obese Children with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病肥胖儿童的维生素D状况与骨密度
J Korean Med Sci. 2015 Dec;30(12):1821-7. doi: 10.3346/jkms.2015.30.12.1821. Epub 2015 Nov 30.
7
Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis.维生素D与非酒精性脂肪性肝病的严重程度无关:配对临床和基因表达谱分析结果
Am J Gastroenterol. 2016 Nov;111(11):1591-1598. doi: 10.1038/ajg.2016.406. Epub 2016 Sep 20.
8
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.脂肪组织功能障碍、维生素 D 缺乏与非酒精性脂肪性肝病发病机制的关系。
World J Gastroenterol. 2017 May 21;23(19):3407-3417. doi: 10.3748/wjg.v23.i19.3407.
9
Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density.非酒精性脂肪性肝病中的骨代谢:维生素D状态与骨密度
Minerva Endocrinol. 2017 Jun;42(2):164-172. doi: 10.23736/S0391-1977.16.02587-6. Epub 2016 Dec 14.
10
Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis.维生素 D 与非酒精性脂肪性肝病:双向孟德尔随机化分析。
EBioMedicine. 2018 Feb;28:187-193. doi: 10.1016/j.ebiom.2017.12.027. Epub 2018 Jan 9.

引用本文的文献

1
Vitamin D inhibits apoptosis in THP-1 cells infected with mycobacterium tuberculosis through TNF signaling pathway.维生素D通过肿瘤坏死因子信号通路抑制结核分枝杆菌感染的THP-1细胞凋亡。
Front Immunol. 2025 May 6;16:1525922. doi: 10.3389/fimmu.2025.1525922. eCollection 2025.
2
Vitamin D 1,25-Dihydroxyvitamin D reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization.维生素D 1,25-二羟基维生素D通过抑制M1巨噬细胞极化减少肝细胞中的脂质积累。
World J Gastrointest Oncol. 2024 Dec 15;16(12):4685-4699. doi: 10.4251/wjgo.v16.i12.4685.
3
Effect of vitamin D supplementation on various parameters in patients with non-alcoholic fatty liver disease: An updated meta-analysis.
补充维生素D对非酒精性脂肪性肝病患者各项参数的影响:一项更新的荟萃分析。
Clin Exp Hepatol. 2023 Dec;9(4):396-404. doi: 10.5114/ceh.2023.133194. Epub 2023 Nov 28.
4
Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.维生素 D 与代谢相关脂肪性肝病(MASLD):新的机制见解。
Int J Mol Sci. 2024 Apr 30;25(9):4901. doi: 10.3390/ijms25094901.
5
The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction.维生素 D 不足对代谢功能障碍个体发生脂肪性肝病的作用。
Sci Rep. 2024 Mar 20;14(1):6714. doi: 10.1038/s41598-024-57380-9.
6
The effect of high oral loading dose of cholecalciferol in non-alcoholic fatty liver disease patients. A randomized placebo controlled trial.高口服负荷剂量胆钙化醇对非酒精性脂肪性肝病患者的影响。一项随机安慰剂对照试验。
Front Pharmacol. 2023 Mar 14;14:1149967. doi: 10.3389/fphar.2023.1149967. eCollection 2023.
7
Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study.非酒精性脂肪肝疾病与维生素 D 在英国生物样本库中的相关性:两样本双向 Mendelian 随机化研究
Nutrients. 2023 Mar 16;15(6):1442. doi: 10.3390/nu15061442.
8
Vitamin D insufficiency and its association with adipokines and atherogenic indices in patients with metabolic syndrome: A case-control study.维生素 D 不足与代谢综合征患者脂联素和动脉粥样硬化指数的关系:一项病例对照研究。
Front Endocrinol (Lausanne). 2023 Jan 20;14:1080138. doi: 10.3389/fendo.2023.1080138. eCollection 2023.
9
Non-alcoholic Fatty Liver Disease and Steatohepatitis: Risk Factors and Pathophysiology.非酒精性脂肪性肝病和脂肪性肝炎:危险因素与病理生理学
Middle East J Dig Dis. 2022 Apr;14(2):167-181. doi: 10.34172/mejdd.2022.270. Epub 2022 Apr 30.
10
The Role of Non-Alcoholic Fatty Liver Disease in Infections.非酒精性脂肪性肝病在感染中的作用。
Life (Basel). 2022 Dec 7;12(12):2052. doi: 10.3390/life12122052.